• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有丝分裂纺锤体破坏后,聚(ADP - 核糖)聚合酶-1(-/-)成纤维细胞中,有丝分裂和有丝分裂后检查点的控制存在缺陷。

Defective control of mitotic and post-mitotic checkpoints in poly(ADP-ribose) polymerase-1(-/-) fibroblasts after mitotic spindle disruption.

作者信息

Halappanavar Sabina S, Shah Girish M

机构信息

Laboratory for Skin Cancer Research, CHUL Research Center (CHUQ), Faculty of Medicine, Laval University, Sainte-Foy, Quebec, Canada.

出版信息

Cell Cycle. 2004 Mar;3(3):335-42. Epub 2004 Mar 1.

PMID:14726664
Abstract

Poly(ADP-ribose) polymerase-1 (PARP), a DNA damage-responsive nuclear enzyme present in higher eukaryotes, is well-known for its roles in protecting the genome after DNA damage. However, even without exogenous DNA damage, PARP may play a role in stabilizing the genome because cells or mice deficient in PARP exhibit various signs of genomic instability, such as tetraploidy, aneuploidy, chromosomal abnormalities and susceptibility to spontaneous carcinogenesis. Normally, cell cycle checkpoints ensure elimination of cells with genomic abnormalities. Therefore, we examined efficiency of mitotic and post-mitotic checkpoints in PARP-/- and PARP+/+ mouse embryonic fibroblasts treated with mitotic spindle disrupting agent colcemid. PARP+/+ cells, like most mammalian cells, eventually escaped from spindle disruption-induced mitotic checkpoint arrest by 60 h. In contrast, PARP-/- cells rapidly escaped from mitotic arrest within 24 h by downregulation of cyclin B1/CDK-1 kinase activity. After escaping from mitotic arrest; both the PARP genotypes arrive in G1 tetraploid state, where they face post-mitotic checkpoints which either induce apoptosis or prevent DNA endoreduplication. While all the G1 tetraploid PARP+/+ cells were eliminated by apoptosis, the majority of the G1 tetraploid PARP-/- cells became polyploid by resisting apoptosis and carrying out DNA endoreduplication. Introduction of PARP in PARP-/- fibroblasts partially increased the stringency of mitotic checkpoint arrest and fully restored susceptibility to G1 tetraploidy checkpoint-induced apoptosis; and thus prevented formation of polyploid cells. Our results suggest that PARP may serve as a guardian angel of the genome even without exogenous DNA damage through its role in mitotic and post-mitotic G1 tetraploidy checkpoints.

摘要

聚(ADP - 核糖)聚合酶 -1(PARP)是一种存在于高等真核生物中的DNA损伤反应性核酶,因其在DNA损伤后保护基因组的作用而闻名。然而,即使没有外源性DNA损伤,PARP也可能在稳定基因组方面发挥作用,因为PARP缺陷的细胞或小鼠表现出各种基因组不稳定的迹象,如四倍体、非整倍体、染色体异常以及对自发致癌的易感性。正常情况下,细胞周期检查点可确保清除具有基因组异常的细胞。因此,我们检测了用有丝分裂纺锤体破坏剂秋水仙酰胺处理的PARP - / - 和PARP + / +小鼠胚胎成纤维细胞中有丝分裂和有丝分裂后检查点的效率。PARP + / +细胞与大多数哺乳动物细胞一样,最终在60小时内从纺锤体破坏诱导的有丝分裂检查点停滞中逃脱。相比之下,PARP - / - 细胞通过下调细胞周期蛋白B1/CDK - 1激酶活性在24小时内迅速从有丝分裂停滞中逃脱。从有丝分裂停滞中逃脱后,两种PARP基因型的细胞都进入G1四倍体状态,在那里它们面临有丝分裂后检查点,该检查点要么诱导细胞凋亡,要么阻止DNA核内复制。虽然所有G1四倍体PARP + / +细胞都通过凋亡被清除,但大多数G1四倍体PARP - / - 细胞通过抵抗凋亡并进行DNA核内复制而变成多倍体。在PARP - / - 成纤维细胞中引入PARP部分增加了有丝分裂检查点停滞的严格性,并完全恢复了对G1四倍体检查点诱导凋亡的敏感性,从而防止了多倍体细胞的形成。我们的结果表明,即使没有外源性DNA损伤,PARP也可能通过其在有丝分裂和有丝分裂后G1四倍体检查点中的作用,充当基因组的守护天使。

相似文献

1
Defective control of mitotic and post-mitotic checkpoints in poly(ADP-ribose) polymerase-1(-/-) fibroblasts after mitotic spindle disruption.有丝分裂纺锤体破坏后,聚(ADP - 核糖)聚合酶-1(-/-)成纤维细胞中,有丝分裂和有丝分裂后检查点的控制存在缺陷。
Cell Cycle. 2004 Mar;3(3):335-42. Epub 2004 Mar 1.
2
Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.黄酮哌啶醇,一种细胞周期蛋白依赖性激酶抑制剂,可防止纺锤体抑制剂诱导的人类癌细胞内复制。
Clin Cancer Res. 2000 Mar;6(3):924-32.
3
Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase.缺乏聚ADP核糖聚合酶的小鼠细胞中p53的诱导缺陷但激活和功能正常。
Oncogene. 1997 Aug 28;15(9):1035-41. doi: 10.1038/sj.onc.1201274.
4
Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest.聚(ADP - 核糖)聚合酶 -1基因敲除细胞对抗肿瘤三唑并吖啶酮C - 1305的易感性增加与永久性G2期细胞周期阻滞有关。
Cancer Res. 2004 Jul 1;64(13):4487-97. doi: 10.1158/0008-5472.CAN-03-3410.
5
Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.抑制聚(ADP - 核糖)聚合酶活性不足以诱导四倍体形成。
Nucleic Acids Res. 2001 Feb 1;29(3):841-9. doi: 10.1093/nar/29.3.841.
6
Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage.Bcl-xL的表达与p53缺失协同作用可克服有丝分裂纺锤体损伤诱导的细胞周期检查点。
Genes Dev. 1996 Oct 15;10(20):2621-31. doi: 10.1101/gad.10.20.2621.
7
Mitotic functions of poly(ADP-ribose) polymerases.聚(ADP-核糖)聚合酶的有丝分裂功能。
Biochem Pharmacol. 2019 Sep;167:33-43. doi: 10.1016/j.bcp.2019.03.028. Epub 2019 Mar 22.
8
Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.对 PARP-1 活性下调的 HeLa 细胞,一种不寻常的 DNA 拓扑异构酶 II 抑制剂化合物 C-1305 的细胞毒性增强,是由于 p53 通路的再激活和有丝分裂检查点的调节。
Biochem Pharmacol. 2010 May 15;79(10):1387-97. doi: 10.1016/j.bcp.2009.12.023. Epub 2010 Jan 11.
9
Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication.聚(ADP-核糖)聚合酶-1介导的聚(ADP-核糖基)化在中心体复制中的单倍剂量不足。
Biochem Biophys Res Commun. 2007 Aug 3;359(3):426-30. doi: 10.1016/j.bbrc.2007.05.108. Epub 2007 May 25.
10
Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.癌栓素 - A4前药在慢性淋巴细胞白血病细胞系中诱导有丝分裂灾难,与半胱天冬酶激活和聚(ADP - 核糖)聚合酶裂解无关。
Clin Cancer Res. 2002 Aug;8(8):2735-41.

引用本文的文献

1
Defective DNA polymerase beta invoke a cytosolic DNA mediated inflammatory response.缺陷型 DNA 聚合酶β会引发细胞质 DNA 介导的炎症反应。
Front Immunol. 2022 Dec 23;13:1039009. doi: 10.3389/fimmu.2022.1039009. eCollection 2022.
2
Neuroprotective Effects of PARP Inhibitors in Models of Alzheimer's Disease.聚腺苷二磷酸核糖聚合酶抑制剂在阿尔茨海默病模型中的神经保护作用。
Cells. 2022 Apr 9;11(8):1284. doi: 10.3390/cells11081284.
3
Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones.通过组蛋白丝氨酸 ADP-核糖基化将 DNA 修复与细胞周期进程联系起来。
Nat Commun. 2022 Jan 13;13(1):185. doi: 10.1038/s41467-021-27867-4.
4
Mitotic functions of poly(ADP-ribose) polymerases.聚(ADP-核糖)聚合酶的有丝分裂功能。
Biochem Pharmacol. 2019 Sep;167:33-43. doi: 10.1016/j.bcp.2019.03.028. Epub 2019 Mar 22.
5
PARP inhibition causes premature loss of cohesion in cancer cells.聚(ADP-核糖)聚合酶(PARP)抑制会导致癌细胞中黏连蛋白过早丢失。
Oncotarget. 2017 Oct 16;8(61):103931-103951. doi: 10.18632/oncotarget.21879. eCollection 2017 Nov 28.
6
Trial watch - inhibiting PARP enzymes for anticancer therapy.试验观察——抑制PARP酶用于抗癌治疗
Mol Cell Oncol. 2015 Jun 10;3(2):e1053594. doi: 10.1080/23723556.2015.1053594. eCollection 2016 Mar.
7
The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory.癌症起始、进展和转移过程中的H19长链非编码RNA——一种提出的统一理论。
Mol Cancer. 2015 Nov 4;14:184. doi: 10.1186/s12943-015-0458-2.
8
Beyond DNA Repair: Additional Functions of PARP-1 in Cancer.超越DNA修复:PARP-1在癌症中的其他功能
Front Oncol. 2013 Nov 27;3:290. doi: 10.3389/fonc.2013.00290.
9
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets.PARP抑制剂在癌症治疗中的应用:神奇子弹但靶点多变
Front Oncol. 2013 Nov 14;3:279. doi: 10.3389/fonc.2013.00279. eCollection 2013.